Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2006
08/24/2006US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization
08/24/2006US20060189649 Mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189646 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
08/24/2006US20060189644 Lipid-modified immune response modifiers
08/24/2006US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors
08/24/2006US20060189617 e.g. 2-(4-tert-butyl-phenyl)-7-[4-(1-ethyl-2-methyl-1H-imidazol-4-ylmethyl)-piperazin-1-yl]-3H-imidazo[4,5-b]pyridine; anticarcinogenic agent; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, or primary hirsutism
08/24/2006US20060189616 2-(4-Tert-Butyl-phenyl)-7-[4-(2-ethyl-5-methyl-3H-imidazol-4-ylmethyl)-piperazin-1-yl]-1H-imidazo[4,5-c]pyridine; oral delivery; bioavailability; luteinizing hormone releasing hormone) receptor antagonists; antifertility agents; hormone inhibitors
08/24/2006US20060189609 1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders
08/24/2006US20060189601 Antibacterial agents
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006US20060188576 Pirenzepine ophthalmic gel
08/24/2006US20060186797 Pi-conjugated compound having cardo structure, process for preparing same and use of same
08/24/2006CA2598465A1 Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
08/24/2006CA2598076A1 Chemical compounds
08/24/2006CA2596015A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
08/23/2006EP1693366A1 Selective 5-HT 6 receptor ligands
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692140A1 Compositions useful as inhibitors of protein kinases
08/23/2006EP1692136A2 Azepinoindole derivatives as pharmaceutical agents
08/23/2006EP1692133A1 Diazabicyclononene derivatives and their use as renin inhibitors
08/23/2006EP1692132A2 Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
08/23/2006EP1692131A2 Methods and compositions for slowing aging
08/23/2006EP1692130A2 Phenanthridinium derivatives as dna binding agents
08/23/2006EP1692113A1 Aryl imidazoles and their use as anti-cancer agents
08/23/2006EP1692112A1 Compounds, compositions, and methods
08/23/2006EP1669357A8 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof
08/23/2006EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
08/23/2006EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
08/23/2006EP1401836B1 Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections
08/23/2006EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone
08/23/2006EP1332144B1 Indole derivatives as pde5-inhibitors
08/23/2006EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
08/23/2006EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/23/2006EP1198232B1 Urea substituted imidazoquinolines
08/23/2006EP1114050B1 Process for the production of a naphthyridine carboxylic acid derivative ( methanesulfonate sesquihydrate )
08/23/2006CN1823069A Process for synthesizing beta-lactamase inhibitor intermediates
08/23/2006CN1823067A Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
08/23/2006CN1823066A Substituted tetrahydro-1h-pyrazolo [3,4-c]pyridines, compositions comprising them, and use
08/23/2006CN1823065A Method for the enantioselective preparation of sulphoxide derivatives
08/23/2006CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders
08/23/2006CN1823043A Hydroxypyridine cgrp receptor antagonists
08/23/2006CN1821247A Camptothecine derivatives and their use
08/23/2006CN1821246A A class of pyrrolo-naphthyridine derivatives
08/23/2006CN1821245A Camptothecine derivative and its preparation
08/23/2006CN1821244A A class of 17-acyl diversine derivatives and its preparing method
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1821229A Processes for preparing benzo[b]thiophene derivatives
08/23/2006CN1271167C Organic electroluminescent element
08/23/2006CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments
08/23/2006CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines
08/23/2006CN1271054C Urea compounds having muscarinic receptor antagonist activity
08/23/2006CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
08/22/2006US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group
08/22/2006US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis
08/22/2006US7094788 A tropane ester derivative for treating asthma, chronic obstractive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal or urinary tracts, and menstrual pain
08/22/2006US7094784 High affinity ligands for nociceptin receptor ORL-1
08/22/2006US7094780 3-aminoquinazolin-2,4-dione antibacterial agents
08/22/2006US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders.
08/22/2006US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating
08/22/2006CA2242102C Quinazoline derivatives as antitumor agents
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006086539A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
08/17/2006WO2006086484A1 Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
08/17/2006WO2006085815A1 Thiazole derivatives, their process for their preparation and their use in therapy
08/17/2006WO2006084917A1 Non steroidal glucocorticoid receptor modulators
08/17/2006WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues
08/17/2006WO2006055245A3 Process for preparing pyrazolopyridine compounds
08/17/2006WO2006052768A3 Process for preparing quinoline compounds and products obtained therefrom
08/17/2006WO2006008636A3 Processes for the preparation of zolpidem and its hemitartrate
08/17/2006WO2005107762A3 Certain chemical entities, compositions, and methods
08/17/2006US20060183908 Heterocyclic compounds, methods of making them and their use in therapy
08/17/2006US20060183907 Novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-1
08/17/2006US20060183906 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors
08/17/2006US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers
08/17/2006US20060183900 enzyme inhibitors such as 2-{4-[4-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-pyrimidin-2-ylamino]-phenyl}-ethanol, useful in treating or ameliorating a kinase mediated, angiogenesis-mediated or hyperproliferative disorder
08/17/2006US20060183870 Triamantane diamondoid nucleus
08/17/2006US20060183768 Compounds
08/17/2006US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents
08/17/2006US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome
08/17/2006US20060183738 Crystalline forms of nevirapine
08/17/2006US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding
08/17/2006US20060183044 Electrophotographic photoreceptor containing asymmetric naphthalenetetracarboxylic acid diimide derivatives and electrophotographic imaging apparatus employing the same
08/17/2006US20060183043 Electrophotographic photoreceptor containing pyridine-substituted asymmetric naphthalenetetracarboxylic acid diimide derivatives and electrophotographic imaging apparatus
08/17/2006US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications
08/17/2006CA2599611A1 Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
08/17/2006CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006CA2597748A1 Non steroidal glucocorticoid receptor modulators
08/17/2006CA2597595A1 Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods
08/17/2006CA2597587A1 Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
08/16/2006EP1690863A1 Novel condensed imidazole derivative
08/16/2006EP1689747A1 1h-imidazo [4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
08/16/2006EP1689746A2 A process for aqueous milling of quinacridone pigments
08/16/2006EP1689739A1 Azole-based kinase inhibitors
08/16/2006EP1689738A2 Heterocyclic anti-migraine agents
08/16/2006EP1689709A1 N-sulfonyldicarboximide containing tethering compounds
08/16/2006EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof
08/16/2006EP1689393A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
08/16/2006EP1689391A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
08/16/2006EP1689390A2 Methods and reagents for the treatment of inflammatory disorders